Prostate Cancer Drug Carries Side Effects, FDA Says ThirdAge An Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug did not extend life and carried significant side effects, scientists for the Food and Drug Administration say.